Literature DB >> 1335338

(+/-)-CP-96,345, a selective tachykinin NK1 receptor antagonist, has non-specific actions on neurotransmission.

Z Y Wang1, R Håkanson.   

Abstract

1. The non-specific effects of the non-peptide tachykinin receptor antagonist (+/-)-CP-96,345, were assessed in several smooth muscle-nerve preparations. The preparations were the iris sphincter muscle of the rabbit and the taenia coli, vas deferens and seminal vesicle of the guinea-pig. 2. (+/-)-CP-96,345 concentration-dependently inhibited the electrically evoked, tachykinin-mediated contractile responses of the iris sphincter and the taenia coli. The pIC50 values were 5.4 +/- 0.2 (mean +/- s.e.mean) and 5.7 +/- 0.08 respectively. 3. (+/-)-CP-96,345 also inhibited non-tachykinin-mediated contractile responses to electrical stimulation of the iris sphincter, taenia coli, vas deferens and seminal vesicle. The pIC50 values were 4.3 +/- 0.02, 4.8 +/- 0.03, 4.7 +/- 0.02 and 4.4 +/- 0.05 respectively. These values differ significantly from the pIC50 values of the inhibition of the tachykinin-mediated response in the iris sphincter and taenia coli. 4. (+/-)-CP-96,345 was without effect on carbachol- and noradrenaline-evoked contractions of the iris sphincter but inhibited carbachol- and prostaglandin F2 alpha (PGF2 alpha)-evoked contractions of the taenia coli. 5. We suggest that (+/-)-CP-96,345, apart from its NK1 receptor blocking activity, induces non-specific suppression of neurotransmission, exerted at both pre- and post-junctional sites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335338      PMCID: PMC1907737          DOI: 10.1111/j.1476-5381.1992.tb14520.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Novel substance P antagonist, CP-96,345, blocks responses of cat spinal dorsal horn neurons to noxious cutaneous stimulation and to substance P.

Authors:  V Radhakrishnan; J L Henry
Journal:  Neurosci Lett       Date:  1991-10-28       Impact factor: 3.046

2.  Species differences in affinities of non-peptide antagonists for substance P receptors.

Authors:  B D Gitter; D C Waters; R F Bruns; N R Mason; J A Nixon; J J Howbert
Journal:  Eur J Pharmacol       Date:  1991-05-17       Impact factor: 4.432

Review 3.  Tetrodotoxin, saxitoxin and their significance in the study of excitation phenomena.

Authors:  C Y Kao
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

Review 4.  Tachykinins.

Authors:  J E Maggio
Journal:  Annu Rev Neurosci       Date:  1988       Impact factor: 12.449

Review 5.  New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization.

Authors:  D Regoli; G Drapeau; S Dion; R Couture
Journal:  Trends Pharmacol Sci       Date:  1988-08       Impact factor: 14.819

6.  A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation.

Authors:  S Leander; R Håkanson; S Rosell; K Folkers; F Sundler; K Tornqvist
Journal:  Nature       Date:  1981-12-03       Impact factor: 49.962

7.  Comparison of spantide II and CP-96,345 for blockade of tachykinin-evoked contractions of smooth muscle.

Authors:  R Håkanson; Z Y Wang; K Folkers
Journal:  Biochem Biophys Res Commun       Date:  1991-07-15       Impact factor: 3.575

8.  Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin function.

Authors:  R M Hagan; S J Ireland; C C Jordan; I J Beresford; M J Deal; P Ward
Journal:  Neuropeptides       Date:  1991-06       Impact factor: 3.286

9.  A potent nonpeptide antagonist of the substance P (NK1) receptor.

Authors:  R M Snider; J W Constantine; J A Lowe; K P Longo; W S Lebel; H A Woody; S E Drozda; M C Desai; F J Vinick; R W Spencer
Journal:  Science       Date:  1991-01-25       Impact factor: 47.728

10.  Neurogenic mechanisms in control of the rabbit iris sphincter muscle.

Authors:  C Wahlestedt; G Bynke; B Beding; P von Leithner; R Håkanson
Journal:  Eur J Pharmacol       Date:  1985-11-19       Impact factor: 4.432

View more
  10 in total

1.  Investigation of the specificity of FK 888 as a tachykinin NK1 receptor antagonist.

Authors:  Z Y Wang; S R Tung; G R Strichartz; R Håkanson
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

2.  Substance P contributes to rapidly adapting receptor responses to pulmonary venous congestion in rabbits.

Authors:  A C Bonham; K S Kott; K Ravi; C T Kappagoda; J P Joad
Journal:  J Physiol       Date:  1996-05-15       Impact factor: 5.182

3.  Non-specific actions of the non-peptide tachykinin receptor antagonists, CP-96,345, RP 67580 and SR 48968, on neurotransmission.

Authors:  Z Y Wang; S R Tung; G R Strichartz; R Håkanson
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

4.  Tachykinins stimulate release of peptide hormones (glucagon-like peptide-1) and paracrine (somatostatin) and neurotransmitter (vasoactive intestinal polypeptide) from porcine ileum through NK-1 receptors.

Authors:  P T Schmidt; L F Rickelt; J J Holst
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

5.  Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.

Authors:  J Culman; B Wiegand; H Spitznagel; S Klee; T Unger
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

6.  Tachykinin receptors mediating responses to sensory nerve stimulation and exogenous tachykinins and analogues in the rabbit isolated iris sphincter.

Authors:  J M Hall; D Mitchell; I K Morton
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

7.  Block of voltage-dependent sodium currents by the substance P receptor antagonist (+/-)-CP-96,345 in neurones cultured from rat cortex.

Authors:  M Caeser; G R Seabrook; J A Kemp
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.

Authors:  S Guard; S J Boyle; K W Tang; K J Watling; A T McKnight; G N Woodruff
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

9.  Presence of neuropeptide Y in the rat seminal vesicle and its effects on noradrenaline- and nerve-induced contractions.

Authors:  M M Iravani; M A Zar
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

10.  Substance P is essential for maintaining gut muscle contractility: a novel role for coneurotransmission revealed by botulinum toxin.

Authors:  Cuiping Li; Maria-Adelaide Micci; Karnam S Murthy; Pankaj Jay Pasricha
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-03       Impact factor: 4.052

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.